2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Frailty in Older Adults: Evidence for a Phenotype

Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907

Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430

A global clinical measure of fitness and frailty in elderly people

Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968

Apixaban versus warfarin in patients with atrial fibrillation

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K. J., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B. L., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,957

Atrial fibrillation as an independent risk factor for stroke: the Framingham study

Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388

Quality of Oral Anticoagulation Control with Warfarin According to Sex: A Cross-Sectional Study

Viana, C. C., Praxedes, M. F. D. S., de Abreu, M. H. N. G., de Sousa, W. J. F. N., Ferreira, C. R. L., Campos, E. I. D. F., da Silva, J. L. P., & Martins, M. A. P. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22010065 · Cited by 1

First-time unprovoked seizures in adults: when and how to treat

Catania, C., Bernasconi‐Xhepa, S., & Seeck, M. (2025) · Clinical Epileptology · doi:10.1007/s10309-025-00745-5 · Cited by 1

From the right ventricle to the descending aorta: a Case Report of complex thrombotic events in a patient with nephrotic syndrome

Chen, J., Zhu, L., Zhou, F., Li, Y., Gu, T., & Xia, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1514801 · Cited by 1

Oral anticoagulant therapy in patients with atrial fibrillation and end-stage chronic kidney disease

Simić, J., & Mihajlovic, M. (2024) · Galenika Medical Journal · doi:10.5937/galmed2412058s · Cited by 1

A comparison of the effects of direct oral anticoagulants versus vitamin K antagonists and antiplatelet agents on the timing and outcomes of hip fracture surgery in patients older than 65 years: the ORTHO-GER-DOAC study

Martini, E., Tozzi, R., Annessi, G., Borgese, L., Lunardelli, M. L., Alfonso, C., Filippo, C., Grandone, E., & Cosmi, B. (2025) · European Geriatric Medicine · doi:10.1007/s41999-025-01198-9 · Cited by 1

Literature-based case analysis of serious adverse drug events associated with edoxaban

Luan, X., Zhou, D., & Zhang, Q. (2025) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-025-03863-1 · Cited by 1

Antithrombotic treatment of cervical artery dissection: A systematic review and meta-analysis

Loufopoulos, G., Papadopoulos, P. P., Spanos, K. T., Giannoukas, A. D., Matsagkas, M. I., & Kouvelos, G. N. (2025) · Vascular Medicine · doi:10.1177/1358863x251346736 · Cited by 1

Serum Concentration of Apixaban in Relation to Renal Function in Older Hospitalized Patients

Mellingsæter, T. C., Molden, E., & Steihaug, O. M. (2025) · Drugs & Aging · doi:10.1007/s40266-025-01232-2 · Cited by 1

Anti-Factor Xa Activity of Apixaban in Extremely Low Body Weight

Wongcharoen, W., Pamarapa, A., Gunaparn, S., & Phrommintikul, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155238 · Cited by 1

Major Bleeding Risk During Concomitant Use of Antiarrhythmic Drugs and Oral Factor Xa Inhibitors: A Nationwide Self-Controlled Case Series Study

Choi, Y., Jeong, J., Heo, K., Shin, J., & Lee, J. (2025) · Thrombosis and Haemostasis · doi:10.1055/a-2679-6101 · Cited by 1

Anticoagulant initiation after cardioembolic stroke: practical timing and options

Manorenj, S., Kumar, S., & Shashanka, C. (2025) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20252872 · Cited by 1

Evaluation of Bleeding and Thrombotic Outcomes of Anticoagulation Strategies Upon Intensive Care Unit Admission for Patients with Atrial Fibrillation on Direct Oral Anticoagulants

Patel, P. J., Sigala, M. I., Dinunno, C. V., Blackburn, L. M., & Donahue, K. R. (2025) · Journal of Pharmacy Practice · doi:10.1177/08971900251376819 · Cited by 1

Potential clinical benefits of proton pump inhibitors for secondary prevention of recurrent bleeding among patients with upper gastrointestinal bleeding receiving oral anticoagulants: a systematic review and meta-analysis

Sutheechai, S., Sirichanchuen, B., Chaipichit, N., & Dilokthornsakul, W. (2025) · International Journal of Pharmacy Practice · doi:10.1093/ijpp/riaf078 · Cited by 1

Real-World Patterns and Outcomes of Anticoagulation Therapy in Pulmonary Embolism: An Observational Dual-Centre Registry Analysis

Jurin, I., Pejić, J., Gjuras, K., Šaler, F., Cvetko, T.-T., Živković, N. P., Mitrović, Z., Manola, Š., Pavlov, M., Blivajs, A., et al. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12100394 · Cited by 1

Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database

Olimpieri, P. P., Palumbo, F. E., Giuffrida, G., Milanetti, E., Gozzo, C., Scebba, E. L., Romano, G. L., Lombardo, G. E., Duminuco, A., Vetro, C., et al. (2025) · Hematology Reports · doi:10.3390/hematolrep17050054 · Cited by 1

Machine learning-based predictive model for atrial arrhythmia following transcatheter atrial septal defect closure

Jacquemyn, X., de Bruaene, A. V., Ector, J., Haemers, P., Meester, P. D., Manlhiot, C., Budts, W., & Vandenberk, B. (2025) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2025.100639 · Cited by 1

Safety and optimal use of direct oral anticoagulant therapy

Laudani, C., Ortega‐Paz, L., Zgheib, A., Khoury, G. E., Alawajneh, M. M., Farahmandsadr, M., Capodanno, D., & Angiolillo, D. J. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2586121 · Cited by 1

Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens

Tang, S., Lin, S., Chen, C., Liu, Y., Ho, L., Kuo, C., Peng, Y., Huang, C., & Jeng, J. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70129 · Cited by 1

Atrial fibrillation in South Africa: anti-arrhythmic and anticoagulation therapy – clinical considerations for pharmacists

Jordaan, B., & Bronkhorst, E. (2025) · SA pharmaceutical journal. · doi:10.36303/sapj.3358 · Cited by 1

Direct Oral Anticoagulant Inhibitors: Mode of Action, Clinical Aspects

Hassan, E., & Will, L. (2025) · Handbook of experimental pharmacology · doi:10.1007/164_2025_786 · Cited by 1

Pharmacist-Led Intervention to Enhance Direct Oral Anticoagulant Adherence and Treatment Outcomes in Atrial Fibrillation: A Pragmatic Clinical Trial

Liu, S., Huang, Y.-M., Lin, S.-Y., & Wang, C. (2026) · Patient Preference and Adherence · doi:10.2147/ppa.s565777 · Cited by 1

Prevention and treatment of thrombosis in patients with decompensated cirrhosis

Bell, C., Afzal, A., Carlin, S., & Roberts, L. N. (2026) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.12.018 · Cited by 1

Direct oral anticoagulants in patients with advanced cirrhosis: is it time?

Camilleri, E., & Lisman, T. (2026) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2026.103350 · Cited by 1

Healthcare professionals’ perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire

de Jong, M. J., Brys, A. D. H., Braeken, D. C. W., Pisters, R., Janssen, D. J. A., Altintas, S., Robben, S. H., Nicolaï, S., Eurlings, C., Zwietering, A., et al. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-06972-3 · Cited by 1

Rivaroxaban treatment discontinuation rates in patients with nonvalvular atrial fibrillation in Italian clinical practice: RITMUS-AF

Pizzi, C., Pagliani, L., Carbonare, L. D., Agostoni, P., Imbalzano, E., Galasso, G., Casella, G., Dasseni, N., Luca, L. D., Porto, I., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341633 · Cited by 1

Perioperative Antikoagulation und Thrombolyse

Rohe, G., Droege, L., & Schaefer, S. T. (2026) · Intensivmedizin up2date · doi:10.1055/a-2360-0736 · Cited by 1

Ischemic and Bleeding Events After Early Initiation of Direct Oral Anticoagulants for Acute Intracranial Hemorrhage With Non-Valvular Atrial Fibrillation ― A Multicenter Prospective Registry ―

Koga, M., Toyoda, Ḱ., Iguchi, Y., Itabashi, R., Kataoka, H., Nakai, M., Tanaka, K., Miwa, K., Kondo, R., Todaka, T., et al. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-0791 · Cited by 1

Contemporary approaches to perioperative anticoagulant management in surgical patients: a literature review

Budiarto, R. M., Luthfah, N., Saputra, P. B. T., Widiarti, W., Aufazhafarin, N. T., Qolbina, F. F., Arba, I. F., Faizah, N. N., & Alkaff, F. F. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2627734 · Cited by 1

Relevance and limitations of clinical follow-up in a pharmacokinetic study on direct oral anticoagulants

Terrier, J. E., Gosselin, P., Combescure, C., Fontana, P., Daali, Y., & Reny, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1761151 · Cited by 1

eGFR imbalance may confound DOAC-VKA comparisons in kidney transplant recipients

Jin, Y., Huang, Z., Zhang, L., & Gan, X. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106805 · Cited by 1

Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries

Mei, D. A., Bucci, T., Romiti, G. F., Corica, B., Shantsila, A., Tse, H.-F. T., Boriani, G., Chao, T., Proietti, M., & Lip, G. Y. H. (2026) · European Journal of Clinical Investigation · doi:10.1111/eci.70193 · Cited by 1

Interpreting observational comparisons of DOACs and VKAs in kidney transplant recipients

Liu, R., & Zhang, P. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106857 · Cited by 1

Periprocedural Factor Xa Inhibitor Interruption and Resumption for Patients With Atrial Fibrillation Undergoing Dental Procedures

Lee, K., Lee, S., Park, J.-S., Lee, Y. S., Oh, Y., Han, S.-J., Namgung, J., Lee, J. H., Lim, W., Ahn, M. S., et al. (2026) · Korean Circulation Journal · doi:10.4070/kcj.2025.0429 · Cited by 1

Identifying risk factors for major bleeding in patients with atrial fibrillation using direct oral anticoagulants: a systematic review and meta-analysis

Wang, X., Pan, M.-M., Wang, J., Gu, Z.-C., Zhang, C., & Lin, H.-W. (2026) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2026.04.001 · Cited by 1

Practical Recommendations for Anticoagulation in Patients With Atrial Fibrillation

Johner, N., & Gencer, B. (2026) · European Journal of Clinical Investigation · doi:10.1111/eci.70224 · Cited by 1

Edoxaban for atrial fibrillation in patients with atherosclerotic disease in daily clinical practice

de Vries, T. A. C., de Groot, J. R., Pisters, R., Hemels, M. E. W., Komen, J. J., Smolnik, R., Fronk, E., Steffel, J., Weiss, T. W., de Asmundis, C., et al. (2026) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-026-03269-5 · Cited by 1

DOACs in cirrhosis: Progress, pitfalls, and the path forward

Loncharich, A. J., Bria, K. E., & Afzal, A. (2026) · Thrombosis Research · doi:10.1016/j.thromres.2026.109722 · Cited by 1

The DOAC ‐ FRAIL Study—Same Dose, Different Story: Prevalence of Deviant Direct Oral Anticoagulant Levels in Nursing Home Residents

Franssen, I. S., de Jong, M. J., Visseren, L., Teerds, D., Hellenbrand, D., Henskens, Y., Spronk, H. M. H., Janssen, D. J. A., Braeken, D. C. W., van Kuijk, S. M. J., et al. (2026) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70559 · Cited by 1

Safety and efficacy of DOACs in clinically complex phenotypes of patients with atrial fibrillation: focus on frailty, multimorbidity and polypharmacy

Papakonstantinou, P. Ε., & Lip, G. Y. H. (2026) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2026.2701663 · Cited by 1

Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer’s disease: a Swedish nationwide study

Zhu, N., Xu, H., Ptacek, S. G., Mitra, S., & Eriksdotter, M. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag584 · Cited by 1

Management of patients with atrial fibrillation and minor bleeding during therapy with direct oral anti-coagulants

Belenkov, Y. N., Popova, L. V., & Ilgisonis, S. I. (2021) · Kardiologiia · doi:10.18087/cardio.2021.12.n1872 · Cited by 1

How to level the risk of bleeding while taking anticoagulant therapy in patients with atrial fibrillation?

Berns, S. A., & Барбараш, О. Л. (2022) · Consilium Medicum · doi:10.26442/20751753.2022.1.201474 · Cited by 1

Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants

Valery, J. R., Marar, A., Pujalte, G. G. A., Ward, C., Abdelmoneim, Y., FITZGERALD, P. J., Mwakyanjala, E. J., Harris, D. M., Murray, L. P., Heckman, M. G., et al. (2022) · Journal of Primary Care & Community Health · doi:10.1177/21501319221118806 · Cited by 1

Systematic screening of atrial fibrillation works, but is this our current priority?

Bo, M., Presta, R., & Brunetti, E. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.09.001 · Cited by 1

Comparison of Outcomes in Patients With Atrial Fibrillation Under Oral Anticoagulation Therapy Analyzed by Body Weight (<60, 60 to 100, and >100 kg)

Erquicia, P. D., Raposeiras‐Roubín, S., Abu‐Assi, E., Bouzon-Iglesias, P., Barcía, J. A. P., Castro, A. L., González-García, A., Caro, V. N., Piñeiro, A. L., Otero, C. I., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.07.028 · Cited by 1

Hemorragia digestiva alta

Hajj, W. E., & Nahon, S. (2022) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(22)47167-4 · Cited by 1

Safety and Feasibility of Catheter Ablation Procedures in Patients with Bleeding Disorders

Feher, M., Saguner, A. M., Kirstein, B., Vogler, J., Eitel, C., Phan, H., Keelani, A., Çimen, T., Hatahet, S., Trajanoski, D., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236956 · Cited by 1

Electric cardioversion in patients treated with oral anticoagulants: embolic material in the left atrial appendage

Karwowski, J., Rekosz, J., Solecki, M., Mączyńska-Mazuruk, R., Wrzosek, K., Syska-Sumińska, J., & Dłużniewski, M. (2023) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2022-060 · Cited by 1

Groin lymphorrhea after catheter ablation of atrial fibrillation: A case report

Santini, M., Đula, K., Radeljić, V., Car, S., Bulj, N., & Zeljković, I. (2022) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2022.12.007 · Cited by 1

Giant left atrial appendage aneurysm with thrombus: a challenging management

Bolt, L., Brngger, A. S., Huber, L. C., & Arrigo, M. (2022) · Cardiovascular Medicine · doi:10.4414/cvm.2022.02213 · Cited by 1

Antithrombotische Therapie

Wille, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-66303-5_9 · Cited by 1

Evaluation of the timing of using direct oral anticoagulants after ischemic stroke for patients with atrial fibrillation

Yu, H.-T., Chen, K., Lin, C., Hsu, C., & Chang, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14456 · Cited by 1

CKD-G 3–5: Antikoagulation bei Vorhofflimmern und Thromboembolien

Heine, G. H. (2023) · Die Nephrologie · doi:10.1007/s11560-023-00654-6 · Cited by 1

Anestesia para braquiterapia

Villablanca, N., González, R., Valls, N., Ganga, M., & Lucero, V. (2023) · Revista Chilena de Anestesia · doi:10.25237/revchilanestv5209031204 · Cited by 1

Persistence to rivaroxaban therapy for stroke prevention in clinical practice in Italy: Rationale and design of the RITMUS-AF prospective observational cohort study

Perna, G. P., Vora, P., Gandini, E., Lusona, C. F., & Tosarello, D. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101229 · Cited by 1

Clinical Use of Direct Oral Anticoagulants and Reversal: Consideration for Vascular Surgeons

Houben, A. M., Bonhomme, V. L., & Sénard, M. (2023) · Journal of Vascular Diseases · doi:10.3390/jvd2020017 · Cited by 1

77/m mit Palpitationen und Schwindel

Pereira, J. F. M. (2023) · Zeitschrift für Allgemeinmedizin · doi:10.1007/s44266-023-00063-x · Cited by 1

Warfarin versus direct oral anticoagulants in South Asian octogenarians: a retrospective review

Ee, S. C. E., Rosario, B. H., Mok, Z. H., Tun, M. H., Razali, S. S. B. Y., & Tan, B. H. (2023) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000001233 · Cited by 1

Ataque cerebrovascular recurrente por fibrilación auricular: perspectivas sobre un problema no resuelto

Sánchez-Acosta, K., Galeano, L., Villarreal, D., Montoya, A., & Bayona, H. (2023) · Revista Colombiana de Cardiología · doi:10.24875/rccar.22000049 · Cited by 1

Anticoagulant therapy during cardiovascular implantable electronic device procedures

Daubaraitė, A., Marinskis, G., & Račkauskas, G. (2023) · Advances in Interventional Cardiology · doi:10.5114/aic.2023.129207 · Cited by 1

Kardiovaskuläre Therapie bei chronischer Nierenerkrankung

Brandenburg, V. M., Saritas, T., Schirmer, S. H., Rogacev, K. S., & Heine, G. H. (2023) · Herz · doi:10.1007/s00059-023-05205-2 · Cited by 1

Anticoagulation

Nieto, R. H., Bengelloun, A. K., Abildúa, B. R., Velasco, M. D. L. P. S., Lozano, M. S., & Alonso, E. C. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.112870 · Cited by 1

Impact of cerebral small vessel disease burden and drug level at admission on direct oral anticoagulant associated intracerebral hemorrhage

Lin, S., Chen, Y., Chen, C., Kuo, C., Liu, Y., Chao, Y., Peng, Y., Huang, C., Tang, S., & Jeng, J. (2023) · European Stroke Journal · doi:10.1177/23969873231205673 · Cited by 1

Safety and Efficacy of Uninterrupted Oral Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation with Different Techniques

Schiavone, M., Gasperetti, A., Filtz, A., Vantaggiato, G., Gobbi, C., Tondo, C., & Forleo, G. B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206533 · Cited by 1

Bedside check of medication appropriateness (BED-CMA) as a risk-based tool for bedside clinical pharmacy services: A proof-of-concept study at the trauma surgery ward

Sijpe, G. V. D., Hublou, W., Declercq, P. E., Metsemakers, W., Sermon, A., Casteels, M., Foulon, V., Quintens, C., & Spriet, I. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.017 · Cited by 1

Which dose of apixaban is suitable for Asian patients with atrial fibrillation who have a serum creatinine < 1.5 mg/dL but an estimated glomerular filtration rate < 50 mL/min?

Tsai, C.-T., Liao, J., Chan, Y., Kuo, L., Liu, C., Lip, G. Y. H., & Chao, T. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101333 · Cited by 1

Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010–2020

Liaw, J., Liaw, D., & Dave, C. V. (2024) · Open Heart · doi:10.1136/openhrt-2023-002515 · Cited by 1

Variability of the anticoagulant effect according to body weight in patients treated with direct oral anticoagulants

Belli, L., Radico, F., Auciello, R., Patti, G., Gallina, S., & Renda, G. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03553-3 · Cited by 1

Transesophageal echocardiography: A bibliometric analysis from 1979 to 2022

Pan, S., Li, Z., Wang, Y., Bing, H., Song, H., & Chu, Q. (2024) · Echocardiography · doi:10.1111/echo.15759 · Cited by 1

Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures

Russo, V., Caiazza, E., Femine, F. D., Pezzullo, E., Sarpa, S., Ianniciello, A., Caturano, A., D’Andrea, A., Golino, P., & Nigro, G. (2024) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-024-07573-1 · Cited by 1

Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysis

Yang, S., Xu, Y., Zhang, Y., Li, D., & Li, X. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128293940240315073345 · Cited by 1

AF-React study: Prevalence of thrombotic events in patients with atrial fibrillation receiving NOACs – real-world data analysis from northern Portugal primary healthcare

Pinto, S. S., Teixeira, A., Henriques, T. S., Monteiro, H. J., & Martins, C. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1273304 · Cited by 1

Antithrombotische Therapie beim akuten Koronarsyndrom

Schäfer, A. (2024) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2171-6892 · Cited by 1

Impact of renal function variability on long-term prognosis in ischemic stroke patients with atrial fibrillation

Wang, X., Sin, C., Teo, K. C., Leung, W. C. Y., Wong, Y., Liu, R. K. C., Fok, J., Ip, B. Y. M., Kwan, H. H., Lee, T. C., et al. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1294022 · Cited by 1

Appropriateness of prescribing profiles and intake adherence to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: analysis of a retrospective longitudinal study using real-world data from Northern Portugal (AF-React Study)

Pinto, S. S., Henriques, T. S., Teixeira, A., Monteiro, H., & Martins, C. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-076108 · Cited by 1

Flapless Dental Implant Surgery in Bleeding Disorders

Benetello, F., Zanon, E., Sbricoli, L., & Bacci, C. (2024) · International Journal of Translational Medicine · doi:10.3390/ijtm4020022 · Cited by 1

Frailty and Atrial Fibrillation: A Closer Look at the FRAIL-AF Trial

Ferreira, R. M. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230671i · Cited by 1

Optimizing anticoagulation therapy for in‐hospital patients on direct oral anticoagulants: a single‐centre modified Delphi study

Capiau, A., Vleeschauwer, J. D., Backer, T. L. M. D., Gevaert, S., Randon, C., Mehuys, E., Boussery, K., & Somers, A. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16159 · Cited by 1

Pathogenesis and potential diagnostic biomarkers of atrial fibrillation in Chinese population: a study based on bioinfor-matics

Wu, X., Li, Y., Pan, J., Jian, K. A. N. G., Pan, X., Xue, C., & Gong, L. (2024) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0027 · Cited by 1

The safety of available pharmacotherapy for stroke prevention in atrial fibrillation

Denas, G., Santostasi, G., & Pengo, V. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2409698 · Cited by 1

Preoperative Cardiovascular Assessment and Perioperative Management of Patients with Esophageal Cancer

Murat, B., Murat, S., & Güvenç, T. S. (2024) · Springer eBooks · doi:10.1007/978-3-031-47024-0_16 · Cited by 1

Safety of direct oral anticoagulants in patients with atrial fibrillation aged 80 years and older: clinical risk factors

Cherniaeva, M. S., Андреевна, А. П., Павлова, А. В., Trifonov, M. I., Egorova, L. A., Maslennikova, O. M., Lomakin, N. V., & Sychev, D. A. (2024) · Russian Medicine · doi:10.17816/medjrf635877 · Cited by 1

Anatomical description of malformations of the neck of the left atrial appendage

Batko, J., Jakiel, R., Krawczyk‐Ożóg, A., Jaśkiewicz, K., Litwinowicz, R. A., Burysz, M., Jakiel, M., Bartuś, K., Bolechała, F., Strona, M., et al. (2024) · Clinical Anatomy · doi:10.1002/ca.24246 · Cited by 1

Plasmatic variability of direct oral anticoagulants in people with atrial fibrillation and previous gastric surgery: a pilot case series

Romoli, M., Vitiello, M., Lotti, E. M., D’Antuono, G., Berardo, A., Faini, C., Tudisco, V., Mastrangelo, V., & Longoni, M. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07937-3 · Cited by 1

Direct-Acting Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis—Where Do We Stand?

Vojjala, N., Peshin, S., Kattamuri, L. P. V., Iqbal, R., Dharia, A. A., Jayakumar, J., Iftekhar, R., Singh, S., Balla, M., Celi, C. V., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13010189 · Cited by 2

Hemostasis and Gingival Healing—Polyurethane Adhesive Postextraction Under Rivaroxaban Therapy in a Rodent Model

Heitzer, M., Winnand, P., Katz, M. S., Grottke, O., Magnuska, Z., Kiessling, F. M., Hölzle, F., & Modabber, A. (2025) · International Journal of Dentistry · doi:10.1155/ijod/3384210 · Cited by 1

Efetividade e Segurança da Edoxabana nos Cuidados Clínicos de Rotina de Pacientes com Fibrilação Atrial no Brasil: Estudo Prospectivo de Acompanhamento de 1 Ano – EdoBRA

Précoma, D. B., da Silva, R. P., Passos, L. C. S., Filho, C. R. H., Silveira, F. S., de Vasconcelos, J. T. M., Zimmermann, S. L., Herdy, A. H., Ritter, A. M. V., Freitas-Alves, D. R., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240589 · Cited by 1

Research progress on the application of nanomaterials in the diagnosis and treatment of venous thromboembolism

Wang, X., Xu, S., Liu, Q., Ye, X., He, H., Zhang, X., Chen, L., Yang, J., & Xing, X. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102820 · Cited by 1

Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study

Luojus, A., Lehto, M., Halminen, O., Lehtonen, O., Niemi, M., Teppo, K., Kuoppala, J., Haukka, J. K., Jukka Putaala, A., Linna, M., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf046 · Cited by 1

Patient preferences for stroke prevention treatments in atrial fibrillation in Asia: A discrete choice experiment

Wang, R., Lu, H., Fernandez, G. S., Krucien, N., Huang, D., Higashiyama, H., Du, J., Ye, X., Tervonen, T., & Quaife, M. (2025) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2025.103084 · Cited by 1

Latin America Multidisciplinary Consensus Panel on Management of Severe Bleeding in the Anticoagulated Patient

Pontes‐Neto, O. M., Noble-Lugo, A., Arenas, A. C. M., Guerra, J. C. D. C., Ceresetto, J. M., Rosales, J. S., Colunga‐Lozano, L. E., Meillón‐García, L. A., Vargas, L., Rodrigues, R. D. R., et al. (2025) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2025.04.010 · Cited by 1

Assessment of Rivaroxaban Plasma Concentration Using Chromogenic Anti‐Xa Assays and UHPLC–MS/MS in Chinese Patients With Atrial Fibrillation

Liu, X., Gu, Y., Zhang, Y., Shen, W., Gu, Z., Zhong, M., Ding, H., & Ma, C.-L. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70088 · Cited by 1

Left atrial appendage closure in patients with prior intracranial bleeding, safety, efficacy, and timing

Calle, D. G., y, L. N.-F., Gutiérrez-García, H., Peral, V., Mesnier, J., Tirado-Conde, G., Barrero-Mier, A. F., Gonzalez, A. M., O’Hara, G. E., López-Mesonero, L., et al. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.07.009 · Cited by 1

Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Panov, A. V. (2021) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2021-07-02 · Cited by 1

Regarding the management of an elderly patient with atrial fibrillation

Бiловол, О. М., & Knyazkova, І. І. (2021) · Medicine of Ukraine · doi:10.37987/1997-9894.2021.8(254).245797 · Cited by 1

Safety and Effectiveness of Direct Oral Anticoagulants vs. Warfarin in Patients With Atrial Fibrillation and Endoscopy-Diagnosed Peptic Ulcer

Wang, C., Huang, C., Wu, V. C., Huang, Y.-C., Wang, H., Kuo, C., Chu, P., Wen, M., Chen, Y.-J., Huang, Y., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.774072 · Cited by 1

Az alsó végtagi endovascularis verőér-beavatkozások során alkalmazott antithromboticus, antikoaguláns terápia szempontjai

Kolossváry, E., Szabó, I., Dósa, E., Csobay-Novák, C., Farkas, K., & Járai, Z. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32336 · Cited by 1

Use of Non-Vitamin K Dependent Oral Anticoagulant in Ischemic Stroke

Park, H., & Yoo, J. (2022) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2022.1.1 · Cited by 1

Tendencias actuales en el tratamiento antitrombótico

Vivas, D., Ferreiro, J. L., Cordero, A., Tello‐Montoliu, A., Roldán, I., Consuegra‐Sánchez, L., Ruiz-Nodar, J. M., Fortuny, E., Gámez, J. M., Roldán, V., et al. (2022) · REC CardioClinics · doi:10.1016/j.rccl.2022.01.001 · Cited by 1

Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention

Spinoni, E. G., Ghiglieno, C., Costantino, S., Battistini, E., Dell’Era, G., Porcellini, S., Santagostino, M., Vecchi, F. D., Renda, G., & Patti, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040986 · Cited by 1

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary

Steffel, J., Verhamme, P. B., Potpara, T., Albaladejo, P., Antz, M., Desteghe, L., Hæusler, K. G., Oldgren, J., Reinecke, H., Roldán, V., et al. (2018) · EP Europace · doi:10.1093/europace/euy054 · Cited by 248

Recommendations on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (Based on 2018 European Heart Rhythm Association Practical Guide)

Popova, L. V., Борисовна, К. Т., Аксенова, М. Б., Васильевна, Х. Т., & Kanevskaya, M. (2019) · Kardiologiia · doi:10.18087/cardio.2019.5.2633 · Cited by 3

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,129

Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary

Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., Kirchhof, P. F., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw058 · Cited by 272